Grants and Contributions:

Back to search

Title:

512889

Agreement Number:

512889

Agreement Value:

$175,631,000.00

Agreement Date:

Apr 11, 2020 - Apr 30, 2050

Description:

The project is in direct response to Canada's fight against COVID-19 and Canada's ability to respond to future pandemics. It will enable the rapid discovery of antibody therapies to treat and prevent COVID-19 and establish a Good Manufacturing Practice antibody production facility for Canada's long-term emergency preparedness.

Organization:

Innovation, Science and Economic Development Canada

Expected Results:

This investment will allow the company to improve its antibody discovery platform by incorporating advanced technologies such as artificial intelligence and machine learning to optimize the quality and speed of discovering antibodies with the strongest potential for a COVID-19 therapeutic antibody, helping improve Canada's ability to respond to future pandemics.

Location:

Vancouver, British Columbia, CA V5Y0A1

Reference Number:

033-2020-2021-Q1-512889

Agreement Type:

Contribution

Report Type:

Grants and Contributions

Recipient Business Number:

838509446

Recipient Type:

For-profit organization

Additional Information:

Please note this update includes a change to improve standardization of reporting across projects. The end date was updated from the end of the work phase (23/03/2024) to the current end date of (30/04/2050). This is not an extension. The end date now reflects the entirety of the agreement duration, including the benefit phase and residual audit period. The original start date was updated to reflect the correct execution date.

Amendment Date

Mar 31, 2026

Recipient's Operating Name:

AbCellera

Recipient's Legal Name:

AbCellera Biologics Inc.

Federal Riding Name:

Vancouver Granville

Federal Riding Number:

59036

Program:

SIF Stream 2 - Growth

Program Purpose:

Encourage R&D that will accelerate technology transfer and commercialization of innovative products, processes and services; Facilitate the growth and expansion of firms in Canada; Attract and retain large scale investments to Canada; and-Advance industrial research, development and technology demonstration through collaboration between academia, non-profit organizations and the private sector.

NAICS Code:

541710

Amendments:

See Amendments